Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Carcinoembryonic antigen (CEA) affects tumorigenesis by enhancing tumor cell survival and by inducing tumor angiogenesis. This study aimed to evaluate baseline CEA serum levels to predict bevacizumab-based therapy effect and survival in patients with metastatic colorectal cancer (mCRC). Two hundred...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Sci
Main Authors: Prager, Gerald W, Braemswig, Kira H, Martel, Alexandra, Unseld, Matthias, Heinze, Georg, Brodowicz, Thomas, Scheithauer, Werner, Kornek, Gabriela, Zielinski, Christoph C
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2014
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317865/
https://ncbi.nlm.nih.gov/pubmed/24850362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12451
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items